MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Dorsal STN and Zona Incerta Stimulation as a Strategy to Reduce Dyskinesia after STN-DBS: A Case Series with Literature Reviews

    O. Phokaewvarangkul, K. Katawatee, R. Seeluangsawat, K. Sanyawat, N. Rattanapitak, R. Bhidayasiri (Bangkok, Thailand)

    Objective: These case series illustrate practical programming strategies and clinical decision-making in real-world DBS practice using the concept of stimulating the dorsal STN or ZI…
  • 2026 International Congress

    Dentatothalamic Projections Mediate Tremor Relief Across Deep Brain Stimulation Targets and Tremor Types

    C. Van-Der-Linden, T. Dembek, V. Visser-Vandewalle, A. Horn, M. Barbe, J. Petry-Schmelzer (Cologne, Germany)

    Objective: To investigate the neuroanatomical hotspots for the suppression of rest, postural and intention tremor in Parkinson’s Disease (PD) and Essential Tremor (ET) treated with…
  • 2026 International Congress

    Cell-type-specific asynchronous aging acceleration across movement disorders

    X. Chen, W. Du, J. Luo, G. Liu (Shenzhen, China)

    Objective: To quantify brain cell-type–specific biological aging across different movement disorders (MDS) and compare similarities and differences in cellular aging patterns among MDS. Background: It…
  • 2026 International Congress

    Diagnostic Validity of PD Identification in a Neurologist-Certified National Drug Reimbursement Registry

    V. Räty, T. Kuusimäki, T. Vahlberg, A-M. Tolppanen, V. Kaasinen (Turku, Finland)

    Objective: To evaluate the diagnostic validity of PD identification in a national drug reimbursement registry requiring neurologist-confirmed diagnoses. Background: Administrative healthcare databases are widely used…
  • 2026 International Congress

    Switching to IPX203 from IPX066 Significantly Improves “Good On” Time and Reduces Motor Fluctuations Under Real-World Conditions

    R. Hauser, M. Bixby, D. Bega, R. Dewey, Iii, G. Banisadr, S. Fisher (Tampa, USA)

    Objective: To evaluate the change in daily “Good On” time and motor fluctuations during conversion of patients from IPX066 to IPX203 as an interim analysis…
  • 2026 International Congress

    Evaluating the Conversion of Immediate-Release and/or Extended-Release Levodopa to IPX203 in Patients with Parkinson’s Disease

    L. Poon, A. Lee, D. Lee, T. Chiao, T. Stiep (San Francisco, USA)

    Objective: This quality improvement (QI) project was conducted to evaluate the impact of the conversion from immediate-release (IR) and/or extended-release (ER) levodopa (LD) to mucoadhesive polymer…
  • 2026 International Congress

    Deciphering the NLRP3-Driven Olfactory–Brain Axis in Parkinson’s disease: Neuroprotective Role of Betulin

    A. Kumar, V. Malhotra (Ahamdabad, India)

    Objective: The present study aimed to elucidate the molecular mechanism underlying bidirectional olfactory–brain dysfunction mediated through NLRP3 inflammasome activation in cellular models of PD and…
  • 2026 International Congress

    Levodopa dosing regimen influences repetitive tongue force maintenance in Parkinson’s disease

    S. Hayasaka, K. Hatori, K. Sato, T. Ogawa, T. Hatano, T. Fujiwara (Urayasu, Japan)

    Objective: To investigate whether levodopa (LD) dosing regimen influences the dynamics of repetitive maximal tongue pressure (MTP) in patients with Parkinson’s disease (PD). Background: Reduced…
  • 2026 International Congress

    Remaining unmet needs in Essential Tremor and Parkinson’s Disease: European Neurologists’ Assessments of Pharmacologic Response and Advanced Therapy Use

    N. Kaempf, á. Sánchez Fraga, C. Tengelin, P. Crivelli, K. Gant, C. Ferrer, A. Grinspan (Frankfurt am Main, Germany)

    Objective: To investigate neurologists’ perceptions of treatment effectiveness and criteria for selecting patients for advanced therapies in essential tremor (ET) and Parkinson’s disease (PD). Background:…
  • 2026 International Congress

    Objective Parkinson’s Diagnosis Using a Novel Accelerometer Assessment and Machine Learning

    L. Jurcaga, E. Amigo, J. Oyaga-Orus, S. Aldea-Campillo, J. Marín-Lahoz, M. Vallejo (Edinburgh, United Kingdom)

    Objective: To evaluate a novel motor assessment using a handheld accelerometer and machine learning to objectively support Parkinson's disease (PD) diagnosis. Background: PD diagnosis is…
  • « Previous Page
  • 1
  • …
  • 146
  • 147
  • 148
  • 149
  • 150
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley